Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants with
a 382-nucleotide deletion (∆382) in the open reading frame 8 (ORF8) region of the genome …

Given the ongoing SARS-CoV-2 pandemic, identification of immunogenic targets against
the coronavirus spike glycoprotein will provide crucial advances towards the development of …

Background Studies have found different waning rates of neutralising antibodies compared
with binding antibodies against SARS-CoV-2. The impact of neutralising antibody waning …

Background Key knowledge gaps remain in the understanding of viral dynamics and immune
response of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection. …

Numerous reports of vascular events after an initial recovery from COVID-19 form our impetus
to investigate the impact of COVID-19 on vascular health of recovered patients. We found …

SARS-CoV-2 is the novel coronavirus responsible for the current COVID-19 pandemic. Severe
complications are observed only in a small proportion of infected patients but the cellular …

Understanding the impact of age on vaccinations is essential for the design and delivery of
vaccines against SARS-CoV-2. Here, we present findings from a comprehensive analysis of …

Background Given the unceasing worldwide surge in COVID-19 cases, there is an imperative
need to develop highly specific and sensitive serology assays to define exposure to …

Background The complications and sequelae of coronavirus disease 2019 (COVID-19) and
their effect on long-term health are unclear, and the trajectory of associated immune …

Methods We conducted a retrospective, observational cohort study of 717 patients with PCR-confirmed
COVID-19 who were hospitalized at the National Centre of Infectious Diseases (…